Clinical Trial Update: Effects of Siliphos-Selenium-Methionine-Alpha Lipoic Acid in Patients With Fatty Liver and Non-alcoholic Steatohepatitis [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating a combination of Siliphos selenium, methionine, and alpha-lipoic acid in fatty liver disease and non-alcoholic steatohepatitis; the stu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-alcoholic Fatty Liver Disease
• Non-alcoholic Steatohepatitis

Drugs mentioned

• Siliphos-Selenium-Methionine-Alpha Lipoic Acid (selenium-methionine-alpha-lipoic acid complex)

Snippet

Sponsor: Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran | Conditions: Liver Disease | Phase 4 | Status: COMPLETED